TREATMENT OF THALASSEMIA MAJOR BY AYURVEDA
Phase 1
- Conditions
- Health Condition 1: null- Diagnosed cases of Thalassemia major
- Registration Number
- CTRI/2016/03/006750
- Lead Sponsor
- IPGT and RA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
Diagnosed cases of Thalassemia major
Exclusion Criteria
Children below 2 years and above 12 years of age.
Cases having HIV, HBV infection, hepatic failure, DM, TB etc.
Patient having BT interval for less than 12 days.
Patient undergone Splenectomy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Establish an adjuvant thera from ayurveda in order to <br/ ><br>1 Prolonging the BT interval <br/ ><br>2 Decrease the serum ferritin level <br/ ><br>3 Enhance the life span of the thalassemic children <br/ ><br>4 Increase the QOL of thalassemic patients <br/ ><br>5 Minimise complication such as iron overloading pain etc <br/ ><br>Timepoint: Establish an adjuvant thera from ayurveda in order to <br/ ><br>1 Prolonging the BT interval <br/ ><br>2 Decrease the serum ferritin level <br/ ><br>3 Enhance the life span of the thalassemic children <br/ ><br>4 Increase the QOL of thalassemic patients <br/ ><br>5 Minimise complication such as iron overloading pain etc <br/ ><br>
- Secondary Outcome Measures
Name Time Method Enhance the life span of the thalassemic children <br/ ><br> Increase the QOL of thalassemic patients <br/ ><br>Timepoint: Prolonging the BT interval <br/ ><br>2 Decrease the serum ferritin level